Motley Fool Asset Management LLC Increases Stock Holdings in HealthEquity, Inc. (NASDAQ:HQY)

Motley Fool Asset Management LLC grew its position in HealthEquity, Inc. (NASDAQ:HQY) by 0.5% in the third quarter, HoldingsChannel reports. The institutional investor owned 111,757 shares of the company’s stock after purchasing an additional 531 shares during the period. Motley Fool Asset Management LLC’s holdings in HealthEquity were worth $8,971,000 at the end of the most recent reporting period.

Other hedge funds have also made changes to their positions in the company. Raymond James Trust N.A. increased its position in HealthEquity by 4.8% during the 3rd quarter. Raymond James Trust N.A. now owns 2,905 shares of the company’s stock worth $238,000 after purchasing an additional 132 shares in the last quarter. Truist Financial Corp increased its position in HealthEquity by 7.0% during the 2nd quarter. Truist Financial Corp now owns 2,864 shares of the company’s stock worth $247,000 after purchasing an additional 188 shares in the last quarter. Nisa Investment Advisors LLC increased its position in HealthEquity by 7.5% during the 2nd quarter. Nisa Investment Advisors LLC now owns 2,854 shares of the company’s stock worth $246,000 after purchasing an additional 198 shares in the last quarter. Elk River Wealth Management LLC increased its position in HealthEquity by 0.3% during the 3rd quarter. Elk River Wealth Management LLC now owns 66,181 shares of the company’s stock worth $5,417,000 after purchasing an additional 217 shares in the last quarter. Finally, Nicolet Advisory Services LLC increased its position in HealthEquity by 5.8% during the 3rd quarter. Nicolet Advisory Services LLC now owns 4,218 shares of the company’s stock worth $330,000 after purchasing an additional 233 shares in the last quarter. Hedge funds and other institutional investors own 99.55% of the company’s stock.

HealthEquity Stock Performance

NASDAQ HQY opened at $101.39 on Wednesday. The firm has a market capitalization of $8.85 billion, a P/E ratio of 84.49, a P/E/G ratio of 1.59 and a beta of 0.55. HealthEquity, Inc. has a 1-year low of $62.10 and a 1-year high of $105.82. The company has a debt-to-equity ratio of 0.51, a current ratio of 4.10 and a quick ratio of 4.10. The business’s 50-day simple moving average is $91.07 and its 200-day simple moving average is $83.17.

HealthEquity (NASDAQ:HQY) last released its quarterly earnings data on Tuesday, September 3rd. The company reported $0.66 earnings per share for the quarter, beating the consensus estimate of $0.50 by $0.16. The business had revenue of $299.93 million for the quarter, compared to analyst estimates of $284.48 million. HealthEquity had a return on equity of 9.01% and a net margin of 9.61%. Equities analysts predict that HealthEquity, Inc. will post 2.27 EPS for the current year.

Insider Buying and Selling

In related news, Director Frank Corvino sold 1,039 shares of the business’s stock in a transaction that occurred on Wednesday, November 6th. The stock was sold at an average price of $96.10, for a total transaction of $99,847.90. Following the transaction, the director now directly owns 3,784 shares of the company’s stock, valued at approximately $363,642.40. The trade was a 21.54 % decrease in their position. The transaction was disclosed in a legal filing with the SEC, which is accessible through the SEC website. Also, Director Robert W. Selander sold 8,250 shares of HealthEquity stock in a transaction that occurred on Wednesday, October 9th. The stock was sold at an average price of $82.98, for a total value of $684,585.00. Following the sale, the director now owns 54,719 shares in the company, valued at $4,540,582.62. This represents a 13.10 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last ninety days, insiders have sold 10,536 shares of company stock valued at $884,517. Corporate insiders own 2.20% of the company’s stock.

Wall Street Analyst Weigh In

HQY has been the subject of a number of recent research reports. Deutsche Bank Aktiengesellschaft lifted their price objective on HealthEquity from $102.00 to $103.00 and gave the stock a “buy” rating in a research report on Wednesday, September 4th. Royal Bank of Canada restated an “outperform” rating and issued a $92.00 price target on shares of HealthEquity in a report on Wednesday, September 4th. The Goldman Sachs Group started coverage on HealthEquity in a report on Friday, November 15th. They issued a “neutral” rating and a $108.00 price target for the company. Barrington Research lifted their price target on HealthEquity from $105.00 to $120.00 and gave the company an “outperform” rating in a report on Monday. Finally, Bank of America lifted their price target on HealthEquity from $100.00 to $120.00 and gave the company a “buy” rating in a report on Wednesday, November 13th. One investment analyst has rated the stock with a hold rating and twelve have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has an average rating of “Moderate Buy” and an average price target of $108.38.

About HealthEquity

HealthEquity, Inc provides technology-enabled services platforms to consumers and employers in the United States. The company offers cloud-based platforms for individuals to make health saving and spending decisions, pay healthcare bills, receive personalized benefit information, earn wellness incentives, grow their savings, and make investment choices; and health savings accounts.